Skip to main content
[Translate to English:]

Novo Nordisk Pharma GmbH

Dr. Robert Haustein, Senior Manager Govermental Affairs, Head of Capital Office, Novo Nordisk Pharma GmbH

 

1. Describe your company in a Tweet! 

Novo Nordisk is a global leader in healthcare, founded in 1923 and headquartered in Denmark. We drive change with the goal of defeating diabetes and other serious chronic diseases such as obesity and rare blood and metabolic disorders. To do this, we are working on breakthrough scientific innovations to the point of curing diseases. We promote access to our products for patients worldwide and are actively engaged in prevention. Novo Nordisk employs around 45,000 people in 80 countries and markets its products in around 170 countries. Around 480 employees work at the German headquarters in Mainz.

 

2. Why do you get involved as a Berlin Partner? 

As an internationally active company with Danish roots, we are convinced of Berlin and its importance for the healthcare industry in Germany and Europe.

 

Exclusive information for Berlin-Partners

Photocredit: © Novo Nordisk

TeilenShare

Weitere
Informationen
Further
Information

Berlin is buzzing: Innovative protection against sports injuries

27.02.2024
Betterguards Technology manufactures adaptors that work like safety belts.

Read more

Annual Report 2023 published

26.02.2024
Berlin is looking ahead with confidence.

Read more

Growth engine Airport Region Berlin Brandenburg

22.02.2024
How the Airport Region Team strengthens the region's growing economy.

Read more

Circular economy in and from Berlin

20.02.2024
Berlin companies are counteracting the consumption of resources with innovative business models.

Read more

Region of the future

15.02.2024
Berlin and the surrounding area is recognised as one of Europe’s leading cities and regions.

Read more

Fashion in focus: Berlin Fashion Week 2024

05.02.2024
From 5 to 8 February, the international fashion scene will meet at runway shows, presentations and side events.

Read more